All Press Releases

Investor Relations Press Releases

  • 3/28/16 4:01 pm EDT
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Goldman Sachs Alzheimer’s Symposium. The webcast will be live on Monday, April 11, 2016 at 12:20p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation. About Biogen Through cutting-edge science andmore...
  • 3/21/16 4:01 pm EDT
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ:BIIB) today announced it will report first quarter 2016 financial results on Thursday, April 21, 2016, before the financial markets open. Following the release of the financials, the Company will host a live webcast where Biogen management will discuss the financial results, at 8:30 am ET. To access the live webcast, please go to the investor relations section of Biogen’s website at www.biogen.com/investorsmore...
  • 2/29/16 4:01 pm EST
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Cowen and Company 36th Annual Health Care Conference. The webcast will be live on Monday, March 7, 2016 at 3:20p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation. About BiogenThrough cutting-edge science andmore...
  • 2/4/16 4:01 pm EST
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Leerink Partners 5th Annual Global Healthcare Conference. The webcast will be live on Thursday, February 11, 2016, at 2:15p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com. An archived version of the webcast will be available for 14 days following the presentation. About BiogenThrough cutting-edge science andmore...
  • 1/27/16 7:15 am EST
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported full year and fourth quarter 2015 results, including full year revenues of $10.8 billion, an 11% increase versus 2014. Full year 2015 Non-GAAP diluted earnings per share (EPS) were $17.01, an increase of 23% versus 2014. Non-GAAP net income attributable to Biogen Inc. for the year was $3.9 billion, an increase of 20% versus the prior year. On a reported basis, GAAP diluted EPS for 2015 were $15.more...